Effect of comorbid psychologic and somatic symptom trajectories on early onset substance use among U.S. youth in the ABCD study
- PMID: 39341186
- PMCID: PMC12051135
- DOI: 10.1016/j.addbeh.2024.108181
Effect of comorbid psychologic and somatic symptom trajectories on early onset substance use among U.S. youth in the ABCD study
Abstract
Background: Adolescent substance use (SU) is often motivated by a desire to alleviate undesirable symptoms. To test the self-medication hypothesis, we examined associations between comorbid psychologic and somatic symptom trajectories across early adolescence and early onset SU.
Methods: Using Adolescent Brain Cognitive Development Study® data, we differentiated youth who reported no SU at baseline based on their comorbid anxiety, depression, pain, somatic and somnolence symptom trajectories. The outcome, early onset SU (by age 13-14 years) was derived from self-reported alcohol (≥full drink), tobacco (full regular/e-cigarette), marijuana, or other drug use over 5 years.
Results: 8311 participants were classified with Asymptomatic (27.8 %), Low/stable (39 %), Moderate/persistent (25.3 %) or High/worsening trajectories (7.9 %) from age 9.97 ± 0.74 to 13.57 ± 0.88 years. Early onset SU was 56 % higher for Moderate-High compared to Asymptomatic-Low symptom trajectory groups (12.5 % vs. 8.5 %; OR 1.56 [95 % CI 1.33, 1.79]). Adjusted for covariates, the High/worsening group was more likely than the Asymptomatic group to report use of any substance (adj.OR 2.13 [95 % CI 1.40, 3.25], Alcohol (adj.OR 2.80 [95 % CI 1.56, 5.02]), Tobacco (adj.OR 2.09 [95 % CI 1.23, 3.55]), and Marijuana (adj.OR 2.33 [95 % CI 1.36, 3.99]). Longitudinal, time-lagged analyses revealed potential feedback effects of earlier depression on subsequent SU, and earlier SU on later depression (p < 0.001).
Conclusion: Higher comorbid symptom trajectories emerging in late childhood increased the likelihood of early onset SU. Since negative feedback loops may contribute to symptom persistency, ongoing and potentially harmful SU for at-risk youth, addressing comorbid symptoms that emerge during late childhood is warranted.
Keywords: Adolescence; Adolescent substance use; Comorbid symptoms; Early onset substance use; Symptom trajectories.
Copyright © 2024. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder.Cochrane Database Syst Rev. 2016 Apr 4;4(4):CD010204. doi: 10.1002/14651858.CD010204.pub2. Cochrane Database Syst Rev. 2016. PMID: 27040448 Free PMC article.
-
Primary-level worker interventions for the care of people living with mental disorders and distress in low- and middle-income countries.Cochrane Database Syst Rev. 2021 Aug 5;8(8):CD009149. doi: 10.1002/14651858.CD009149.pub3. Cochrane Database Syst Rev. 2021. PMID: 34352116 Free PMC article.
-
Pharmacological interventions for people with borderline personality disorder.Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD012956. doi: 10.1002/14651858.CD012956.pub2. Cochrane Database Syst Rev. 2022. PMID: 36375174 Free PMC article.
-
Psychosocial interventions for cannabis use disorder.Cochrane Database Syst Rev. 2016 May 5;2016(5):CD005336. doi: 10.1002/14651858.CD005336.pub4. Cochrane Database Syst Rev. 2016. PMID: 27149547 Free PMC article.
-
Sertindole for schizophrenia.Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034864 Free PMC article.
Cited by
-
Scoping review of biological and psychosocial pathways that lead from childhood adversity to early-onset substance use.Front Psychiatry. 2025 Jun 18;16:1612494. doi: 10.3389/fpsyt.2025.1612494. eCollection 2025. Front Psychiatry. 2025. PMID: 40606818 Free PMC article. Review.
References
-
- Achenbach T, Rescorla L (2001). Manual for the ASEBA school-age forms & profiles. University of Vermont, Research Center for Children, Youth & Families, Burlington, VT.
-
- Barch DM, Albaugh MD, Avenevoli S, Chang L, Clark DB, Glantz MD, Hudziak JJ, Jernigan TL, Tapert SF, Yurgelun-Todd D, Alia-Klein N, Potter AS, Paulus MP, Prouty D, Zucker RA, & Sher KJ (2018). Demographic, physical and mental health assessments in the adolescent brain and cognitive development study: Rationale and description. Developmental Cognitive Neuroscience, 32, 55–66. - PMC - PubMed
MeSH terms
Grants and funding
- U24 DA041147/DA/NIDA NIH HHS/United States
- U01 DA051039/DA/NIDA NIH HHS/United States
- U01 DA041120/DA/NIDA NIH HHS/United States
- U01 DA051018/DA/NIDA NIH HHS/United States
- U01 DA041093/DA/NIDA NIH HHS/United States
- U24 DA041123/DA/NIDA NIH HHS/United States
- U01 DA051038/DA/NIDA NIH HHS/United States
- U01 DA041134/DA/NIDA NIH HHS/United States
- U01 DA051037/DA/NIDA NIH HHS/United States
- U01 DA051016/DA/NIDA NIH HHS/United States
- U01 DA050989/DA/NIDA NIH HHS/United States
- U01 DA041106/DA/NIDA NIH HHS/United States
- U01 DA041117/DA/NIDA NIH HHS/United States
- U01 DA041148/DA/NIDA NIH HHS/United States
- U01 DA041174/DA/NIDA NIH HHS/United States
- R01 DA052310/DA/NIDA NIH HHS/United States
- U01 DA041156/DA/NIDA NIH HHS/United States
- U01 DA050987/DA/NIDA NIH HHS/United States
- U01 DA041089/DA/NIDA NIH HHS/United States
- U01 DA050988/DA/NIDA NIH HHS/United States
- U01 DA041028/DA/NIDA NIH HHS/United States
- U01 DA041048/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical